Norges Bank Denali Therapeutics Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $12.3 Million - $19.1 Million	823,941 New	823,941 $19.1 Million
Q4 2023 Feb 09, 2024	BUY	$16.2 - $23.18 $18.7 Million - $26.7 Million	1,152,646 New	1,152,646 $24.7 Million
Q3 2023 Nov 13, 2024	BUY	$20.63 - $30.17 $16.6 Million - $24.3 Million	803,892 New	803,892 $16.6 Million
Q3 2023 Nov 13, 2023	SELL	$20.63 - $30.17 $19.5 Million - $28.5 Million	-943,404 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$23.37 - $32.96 $5.69 Million - $8.03 Million	-243,607 Reduced 29.57%	580,334 $17.1 Million
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $19.4 Million - $27.4 Million	-831,809 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$21.91 - $32.67 $21.2 Million - $31.7 Million	969,440 New	969,440 $22.3 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $26.9 Million - $34.7 Million	1,024,206 New	1,024,206 $28.5 Million
Q3 2022 Nov 13, 2023	BUY	$25.97 - $38.53 $24.5 Million - $36.3 Million	943,404 New	943,404 $29 Million
Q2 2022 Aug 14, 2023	BUY	$20.88 - $35.19 $17.4 Million - $29.3 Million	831,809 New	831,809 $24.5 Million
Q1 2022 May 12, 2023	SELL	$29.0 - $47.27 $5.17 Million - $8.42 Million	-178,143 Reduced 17.39%	846,063 $27.2 Million
Q1 2022 May 09, 2022	SELL	$29.0 - $47.27 $24.5 Million - $40 Million	-846,109 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$42.59 - $55.02 $36 Million - $46.6 Million	846,109 New	846,109 $37.7 Million
Q3 2021 Nov 14, 2022	BUY	$48.48 - $78.23 $41.4 Million - $66.8 Million	853,356 New	853,356 $43.1 Million
Q3 2021 Nov 05, 2021	SELL	$48.48 - $78.23 $36 Million - $58 Million	-741,980 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$50.3 - $78.44 $37.3 Million - $58.2 Million	741,980 New	741,980 $58.2 Million
Q2 2021 Aug 10, 2021	SELL	$50.3 - $78.44 $30.1 Million - $46.9 Million	-597,766 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$53.8 - $81.53 $32.2 Million - $48.7 Million	597,766 New	597,766 $34.1 Million
Q1 2021 May 07, 2021	SELL	$53.8 - $81.53 $46.1 Million - $69.8 Million	-856,429 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$36.89 - $93.56 $31.6 Million - $80.1 Million	856,429 New	856,429 $71.7 Million
Q4 2020 Feb 10, 2021	SELL	$36.89 - $93.56 $33.4 Million - $84.8 Million	-906,373 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$23.13 - $38.84 $21 Million - $35.2 Million	906,373 New	906,373 $32.5 Million
Q3 2020 Nov 10, 2020	SELL	$23.13 - $38.84 $21.6 Million - $36.2 Million	-932,579 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$16.01 - $28.82 $14.9 Million - $26.9 Million	932,579 New	932,579 $22.6 Million
Q2 2020 Aug 07, 2020	SELL	$16.01 - $28.82 $15.2 Million - $27.3 Million	-948,538 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$14.2 - $27.98 $13.5 Million - $26.5 Million	948,538 New	948,538 $16.6 Million
Q1 2020 May 08, 2020	SELL	$14.2 - $27.98 $8.85 Million - $17.4 Million	-623,538 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$14.4 - $19.99 $8.98 Million - $12.5 Million	623,538 New	623,538 $10.9 Million
Q4 2019 Feb 12, 2020	SELL	$14.4 - $19.99 $8.98 Million - $12.5 Million	-623,538 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$15.32 - $21.92 $9.55 Million - $13.7 Million	623,538 New	623,538 $9.55 Million
Q3 2019 Nov 08, 2019	SELL	$15.32 - $21.92 $8.82 Million - $12.6 Million	-575,462 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$18.5 - $28.14 $10.6 Million - $16.2 Million	575,462 New	575,462 $11.9 Million
Q2 2019 Aug 09, 2019	SELL	$18.5 - $28.14 $10.6 Million - $16.2 Million	-575,462 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$17.99 - $24.65 $10.4 Million - $14.2 Million	575,462 New	575,462 $13.4 Million
Q2 2018 Jul 23, 2018	SELL	$15.25 - $21.02 $4.05 Million - $5.58 Million	-265,616 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$15.36 - $24.8 $4.08 Million - $6.59 Million	265,616 New	265,616 $5.23 Million
Q1 2018 May 09, 2018	SELL	$15.36 - $24.8 $9.98 Million - $16.1 Million	-650,000 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$15.04 - $21.45 $9.78 Million - $13.9 Million	650,000	650,000 $10.2 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account